Dihydrosanguinarine

From WikiMD's WELLNESSPEDIA

Dihydrosanguinarine is a benzophenanthridine alkaloid derived from the Papaveraceae family of plants. It is a naturally occurring compound with potential therapeutic applications in the field of medicine and pharmacology.

Chemical Structure[edit]

Dihydrosanguinarine has a complex chemical structure, characterized by a benzophenanthridine skeleton. This structure is common to a group of alkaloids known as the benzophenanthridine alkaloids, which also includes sanguinarine, chelerythrine, and macarpine.

Chemical structure of Dihydrosanguinarine

Pharmacological Properties[edit]

Dihydrosanguinarine exhibits a range of pharmacological properties. It has been studied for its potential anti-cancer, anti-inflammatory, and anti-microbial effects.

Anti-Cancer Properties[edit]

Dihydrosanguinarine has been shown to inhibit the growth of certain types of cancer cells in vitro. This is thought to be due to its ability to interfere with the cell cycle and induce apoptosis, or programmed cell death.

Anti-Inflammatory Properties[edit]

In addition to its potential anti-cancer effects, dihydrosanguinarine also exhibits anti-inflammatory properties. It has been shown to inhibit the production of pro-inflammatory cytokines, which are small proteins that play a key role in the body's inflammatory response.

Anti-Microbial Properties[edit]

Dihydrosanguinarine has also been studied for its potential anti-microbial effects. It has been shown to exhibit activity against a range of bacteria and fungi, suggesting potential applications in the treatment of infectious diseases.

Potential Therapeutic Applications[edit]

Given its range of pharmacological properties, dihydrosanguinarine has potential therapeutic applications in a number of areas. These include the treatment of cancer, inflammatory diseases, and infectious diseases. However, further research is needed to fully understand the potential of this compound and to develop it into a clinically useful drug.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.